The Heart Research Institute offers multiple Summer Undergraduate Scholarships to Australia's best and brightest young researchers.
This is an outstanding opportunity for talented researchers to develop their skills and gain valuable experience at state-of-the-art research facilities. High calibre scientists, new technologies and cutting-edge equipment are just a few features that make this an exciting opportunity for promising undergraduate students.
The seven-week scholarship provides high-achieving and promising students the opportunity to work on a medical research project directly related to cardiovascular disease, expand on their skills and knowledge, and be mentored in a world-class research institute. Scholarship recipients will be required to write a report on their work experience and will have the opportunity to make a presentation to their peers and supervisors at the end of the scholarship period.
Placements are full-time. The 2022 Summer Scholarships will run 6 January to 25 February 2022. Note that the Summer Scholarship program may be cancelled at any time if travel restrictions or health regulations require it. HRI has strong COVID-safe protocols in place, including regular onsite COVID testing.
Applications are now open for the 2022 Summer Scholarships. Applications close 5pm, 19 September 2021.
Scholarships are open to students currently enrolled full-time in an undergraduate degree. Students currently enrolled in graduate entry medical degrees can also apply.
Scholarships will be based on the strength of the application and successful candidates will be required to give an oral presentation and submit a written report of their research at the end of the scholarship. Beyond their scholarship, students may progress to further opportunities with HRI, including the opportunity to undertake Honours or PhD projects.
To be eligible, students must:
- be an Australian or New Zealand permanent resident
- be an undergraduate student in their second or third year of university
- commit to HRI values and responsibilities
- provide proof of university enrolment and end of year results
- attend an interview via Skype or face-to-face
- have had their first dose of a COVID-19 vaccine or be fully vaccinated by the start of the placement period.
HRI's mission is to prevent death and suffering from cardiovascular disease. The wide variety of scientific groups at HRI each conduct cutting-edge research into a specific aspect of the disease. These include stroke, hypertension, atherosclerosis, bioengineering, biomaterials, medical devices and thrombosis.
Find out more about our research areas here. You will be allocated a project within one of these research themes, and while you are here, you will have the opportunity to liaise with scientists across all of HRI’s research areas.
Postdoctoral scientists will provide mentorship, leadership and provide regular feedback, with Group Leaders overseeing.
Students will receive a stipend payment.
Applications will be assessed by senior HRI scientists on the basis of academic merit and suitability. Applications must include:
- a one-page cover letter outlining your reasons for applying and your interest in research
- your academic record (including certified academic transcript for current degree)
- your CV including referees (a summary of your work experience and other relevant activities)
- a copy of your passport photo page or residency document.
Please submit your application all together as ONE PDF document, using the following naming convention: lastname_firstname_2022.
Applications must be received no later than 5pm on 19 September 2021.
Note: This Scholarship is a Category A position according to the NSW Health Policy - Occupational Assessment, Screening Vaccination Against Specified Infectious Diseases. Successful applicants will be required to provide evidence of protection against the infectious diseases specified, at their own cost, prior to commencing with HRI.
Please complete the form below and attach your application document. All candidates will be contacted once applications have been reviewed and shortlisted.